allergies and asthma paul keith md msc frcpc mcmaster university president, canadian society of...
TRANSCRIPT
![Page 1: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/1.jpg)
Allergies and Asthma
Paul Keith MD MSc FRCPC
McMaster UniversityPresident, Canadian Society of Allergy and Clinical Immunology
![Page 2: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/2.jpg)
DISCLOSURE INFORMATION
I have the following financial relationship to disclose:
Consultant for: CSL Behring, GSK, Merck, Novartis, Takeda, Viropharma
Grant/Research support from: CSL Behring, GSK, Merck, Shire
Honoraria from: CSL Behring, GSK, Merck, Takeda
Name: Dr. Paul Keith
![Page 3: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/3.jpg)
CSACI Mission:
“…is the advancement of the knowledge and practice of allergy, clinical immunology, and asthma for optimal patient care.
The Society is also dedicated to improving the quality of life of people with allergies through research, advocacy, and continuing professional development and public education."
![Page 4: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/4.jpg)
TRUE or FALSE?
1. Intranasal steroids are first line for the treatment of rhinitis when moderate congestion is present
2. Exposure to hand sanitizer is associate with increased rate of allergen sensitization
3. Allergy specific IgE levels go up as you Vitamin D levels go down
![Page 5: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/5.jpg)
Father's desperate screams spur CPR rescue
THE HAMILTON SPECTATOR Aug 27, 2010 Jordan Hertz, a 12-year-old asthmatic
boy from east Hamilton, "He has severe asthma, and during the
day he said, 'Dad, I can't breathe,'" said Hertz. "That's a sign for me to rush him to the hospital."
While racing to Hamilton General, Jordan began saying, "I can't breathe, I can't breathe." His father called 911 on his cellphone and went to pull over. Before he could stop and give his son a puff from a rescue inhaler, Jordan lost consciousness.
The patient was 'vital signs absent' upon arrival
![Page 6: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/6.jpg)
Inverse Relation between the Incidence of Prototypical Infectious Diseases (Panel A) and the Incidence of Immune Disorders (Panel B) from 1950 to 2000.
Bach J. N Engl J Med 2002;347:911-920.
![Page 7: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/7.jpg)
![Page 8: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/8.jpg)
Age-adjusted Australian hospital admission rates for anaphylaxis
1993-2005
*Rate per million population
Mullens RJ. Med J Aust 2007; 186 (12): 618-621.
![Page 9: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/9.jpg)
The atopic march
![Page 10: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/10.jpg)
Baatenburg de Jong A et al. Pediatr Allergy Immunol 2009;20:735
Food
Inhalant
Age in yrs
![Page 11: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/11.jpg)
![Page 12: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/12.jpg)
miliaseptumturrbinate
![Page 13: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/13.jpg)
Asthma
Before
10 Minutes After Allergen Challenge
Laitinen et al. J Allergy Clin Immunol. 1992;90:32-42.
![Page 14: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/14.jpg)
Eosinophilic Esophagitis
![Page 15: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/15.jpg)
Allergy skin prick testing
![Page 16: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/16.jpg)
IgE-dependent Release of Inflammatory Mediators
Immediate ReleaseGranule contents:Histamine, TNF-, Proteases, Heparin
Over MinutesLipid mediators: ProstaglandinsLeukotrienes
Over HoursCytokine production:Specifically TNF-a, IL-4, IL-13
IgE
FcRI
FcRIbinding site
Cell recruitment
Sneezing Nasal congestionItchy, runny noseWatery eyes
WheezingBronchoconstriction
![Page 17: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/17.jpg)
Priming:Increased
responsiveness to repeated
allergen exposure
IgE Ab
Mast cell
Release of histamine and
other mediators
Early-phase reaction
Sneezing, rhinorrhoea, congestion, eye
symptoms
Antigen
Eosinophils
Late-phase reaction
Cellular Infiltration
Allergic inflammation and priming
Naclerio R, manuscript in development.
![Page 18: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/18.jpg)
![Page 19: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/19.jpg)
![Page 20: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/20.jpg)
![Page 21: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/21.jpg)
![Page 22: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/22.jpg)
![Page 23: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/23.jpg)
![Page 24: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/24.jpg)
Mould
![Page 25: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/25.jpg)
• sampled 46 rooms in 4 urban elementary schools (northeastern United States) and from 38 student bedrooms
Sheehan WJ et al Ann Allergy Asthma Immunol 2009 Feb;102(2):125-30
![Page 26: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/26.jpg)
Epidemiology of allergic rhinitis in adults
Bauchau V, Durham SR. Eur Respir J 2004;24:758–64.
0
10
20
30
Belgium France Germany Italy Spain UK
% g
ener
al p
op
ula
tio
n
Prevalence of allergic rhinitis (AR) in European adults during 2001
![Page 27: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/27.jpg)
Do you have nasal congestion or nasal symptoms?
• 44% of eligible respondents reported either nasal congestion or nasal symptoms.
• 20 % had been diagnosed with AR by a physician
n=3,671
![Page 28: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/28.jpg)
Allergies in Canada Survey: Symptom control in worst month ( n=1001)
![Page 29: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/29.jpg)
Allergies in Canada Survey: symptoms during worst month (n=1001)
35
29
23
21
22
16
7
8
6
11
5
32
30
30
27
19
18
17
15
14
10
7
17
15
17
13
12
14
18
13
14
7
11
0 20 40 60 80 100
stuffed nose
sneezing
runny nose
watering eyes
itchy nose
post-nasal drip
headache
sleep loss
facial pain
loss of smell
ear symptoms
daily few days/week few days/month
![Page 30: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/30.jpg)
Concomitant treatment in 6829 Canadians with SAR at baseline
Keith PK et al. Clin Ther 2007
30 352520151050% of patients
INS
Oral nonsedating antihistamine
Ophthalmic drugs
Immunotherapy
Oral sedating antihistamineTopical nasal decongestant
Oral nasal decongestant
Intranasal antihistamine
Oral corticosteroid
Cromolyn
Intranasal anticholinergic
INS, intranasal corticosteroid; SAR, seasonal allergic rhinitis
![Page 31: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/31.jpg)
Visits for allergic rhinitis are infrequent
44% >1yearor never
12%13% 13%
16%
29%
15%
Past month Past 3 months Past 6 months Past 12 months Greater than 1 year ago Never
DISCUSSED ALLERGY WITH PHYSICIAN
Q11: When was the last time you discussed your allergies and/or allergy medication(s) with your physician?
![Page 32: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/32.jpg)
Most patient’s symptoms are not at least mostly controlled
9%
16%
34%
37%
4%
Not at all A little Somewhat Mostly Fully
SYMPTOMS CONTROLLED
Q3: How well do you consider your allergy symptoms controlled?
![Page 33: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/33.jpg)
Most patient’s symptoms are not at least mostly controlled
9%
16%
34%
37%
4%
Not at all A little Somewhat Mostly Fully
SYMPTOMS CONTROLLED
Q3: How well do you consider your allergy symptoms controlled?
59% not controlled
![Page 34: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/34.jpg)
Impact of allergic rhinitis on patients’ daily life
1. Scadding G et al. EAACI 2007, Abstract 1408. 2. Reilly MC et al. Clin Drug Invest 1996;11:278–88. 3. Tanner LA et al. Am J Manag Care 1999;5(Suppl 4):S235–S247. 4. Blanc PD et al. J Clin Epidemiol 2001;54:610–18. 5. Juniper EF et al. J Allergy Clin Immunol 1994;93:413–23. 6. Marshall PS, Colon EA. Ann Allergy 1993;71:251–8.
SLEEP AND TIREDNESS• 46% of patients feel tired1
• 77% of patients have trouble falling asleep1
WORK AND SCHOOL PRODUCTIVITY
• ≤90% effectiveness at work4
• 93% impaired classroom performance3,5
EMBARRASSMENT• Adolescents embarrassed to
use inhalers6
Impact ofallergicrhinitis
DAILY ACTIVITIESIMPAIRED2,3
LEARNING AND COGNITIVEFUNCTIONS DISTURBED6
![Page 35: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/35.jpg)
True or false?
l Asthma is more common in the population than allergic rhinitis
![Page 36: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/36.jpg)
• Up to 40% of patients
with allergic rhinitis also
have asthma
• Up to 94% of patients
with allergic asthma also
have allergic rhinitis
AR-Asthma relationship
Allergic rhinitisalone
AR+
asthmaAsthma alone
![Page 37: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/37.jpg)
True or false?
l Asthma is more common in the population than allergic rhinitis
FALSE
![Page 38: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/38.jpg)
Risk of developing asthma over time
Shaaban R et al Lancet 2008; 372: 1049–57
![Page 39: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/39.jpg)
First Line Therapies for Patients with Allergic Rhinitis and Asthma
Leukotriene receptor antagonists
Topical Corticosteroids
(nasal and pulmonary)
Adapted from Corren J AAAAI 2006
Anthistamines
![Page 40: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/40.jpg)
INS vs LTRA vs LTRA+AH vs placebo started prior to season
Pullerits T et al. JACI 2002;109:949-55
![Page 41: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/41.jpg)
FPANS= intranasal steroid, ML= LTRA, LT= antihistamine
Pullerits T et al. JACI 2002;109:949-55
![Page 42: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/42.jpg)
Copyright ©1998 BMJ Publishing Group Ltd.
Weiner, J. M et al. BMJ 1998;317:1624-1629
Intranasal steroids vs oral antihistamines
![Page 43: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/43.jpg)
Treatment of Allergic Rhinitis
Class IMild /
intermittent
Class IIModerate/intermittent
Moderate-severe / intermittent
Severe/ intermittent
Mild / persistent
Class III
Moderate / persistent
Class IVModerate – severe /
persistent
Severe/persistent
Surgery
Immunotherapy
Oral steroids
LTRAs
Intranasal corticosteroids
Oral H1 antihistamines
Allergen / irritant avoidanceSmall et al. J Otolaryngol. 2007
![Page 44: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/44.jpg)
Strength of evidence for treatment of rhinitisARIA update 2007
intervention SAR PAR Persistent adult child adult child rhinitis
oral anti-H1 A A A A A
intranasal CS A A A A A**
intranasal chromone A A A A
anti-leukotriene A A A A**
Anti-IgE mab A A A A A**
Subcutaneous IT A A A A A**
Allergen avoidance D D A* B*
* Not effective in general population
** extrapolated from studies in PAR/SAR
![Page 45: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/45.jpg)
Mea
n c
han
ge
in p
atie
nt-
rep
ort
ed n
asal
co
ng
esti
on
sc
ore
fro
m b
asel
ine
(%)
Days
1-15 16-30 31-45 46-60 61-75 76-90
Mandl et al. Ann Allergy Asthma Immunol. 1997;79:370.
Moderate to severe perennial allergic
Mean % Reduction in Patient-Rated Congestion* From Baseline
EndpointBaseline
† †
†
†
†
†
†
†
†
†
†
†
†
†
†
Mometasone
![Page 46: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/46.jpg)
Growth in children with perennial allergic rhinitis taking nasal mometasone furoate
Mometasone 100 µg/day
Placebo
Month*p=0.02 (6.9 cm vs 6.3 cm)
Schenkel et al. Pediatrics 2000;105:E22
Mean change in height from baseline (mm)
*
![Page 47: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/47.jpg)
Nasal Biopsies
Long-term treatment with mometasone:No evidence of nasal atrophy
Minshall et al. Otolaryngol Head Neck Surg. 1998;118:648.
Before mometasone treatment: After 12 Months of mometasone 200 µg/day treatment:
Disruption of epithelium
Eosinophil infiltration
Epithelium intact
No eosinophil infiltration
![Page 48: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/48.jpg)
Pharmacologic management of mucosal congestion
Allergic Rhinitis Nasal Polyps
Acute Rhinosinusitis
Mucosal Congestion2 sprays OD 2 sprays BID
2-4 sprays BID
![Page 49: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/49.jpg)
First and Second Line Therapies for Patients with Allergic Rhinitis and Asthma
Leukotriene receptor antagonist
Topical Corticosteroids
(nasal and pulmonary)
Anthistamines
Anti-IgE Immunotherapy
![Page 50: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/50.jpg)
Immunotherapy(high dose Ag)
Th1
IFNg
IgG
Tr
IL-10 TGF-b
IgG4 IgA
APC
Natural exposure (low dose Ag) + IgE
Th2
B cell
Eosinophil
IgE
IL-4
IL-5
Allergy(-)
(-)
Robinson DS, Larche ML and Durham SR. J Clin Invest 2004; 114: 1389-97
![Page 51: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/51.jpg)
SLIT = sublingual immuntherapy
![Page 52: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/52.jpg)
SLIT for asthma, rhinitis, and conjunctivitis symptoms adults and
children
Calamita Z et al. Allergy 2006;61:1162
![Page 53: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/53.jpg)
165
119
65
51
28
0
20
40
60
80
100
120
140
160
180
Respiratoryinfections
Hypertension Disorders oflipid
metabolism
Diabetesmellitus
Depressivedisorder
Source: Verispan PDDA 2004
Num
ber o
f com
mon
offi
ce
visi
ts (m
illio
ns)
Respiratory infections are the # 1 reason for physician office visits
![Page 54: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/54.jpg)
1.9 Million patient visits (96.6% treated with drugs)
MAT Dec 2008 IMS CDTI
1.4 Million patient visits (80.1% treated with drugs)
Therapeutic Profile
Acute Sinusitis Chronic Sinusitis
NIS MT4%
Other21%
NIS Adjunct
18%
Antibiotics54%
Nasal Steroids
23%
Other17%
Antibiotics60%
Untreated3%
![Page 55: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/55.jpg)
Macrolide-resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-
2008
0
5
10
15
20
25
Per
cent
age
of I
sola
tes
Res
ista
nt t
oE
ryth
rom
ycin
1988
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Canadian Bacterial Surveillance Network, Feb 2009
![Page 56: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/56.jpg)
Rates of Penicillin and Amoxicillin Resistance Canada: 1988-2008
0
1
2
3
4
5
6
7
8% Penicillin Resistance% Amoxicillin Resistance
Canadian Bacterial Surveillance Network, March 2008
![Page 57: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/57.jpg)
Figure 2 Kaplan Meier curves presenting the probability of asthma hospitalization in 30,675 children from the DNBC, who were exposed to maternal use of antibiotic for nonrespiratory infection during pregnancy (N=162) versus children who were not exposed to maternal antibiotic use during pregnancy (N = 1036).
Use of Antibiotics during Pregnancy Increases the Risk of Asthma in Early Childhood
Graff L et al. The Journal of Pediatrics 2012; Nov 6. pii: S0022-3476(12)01141-9
![Page 58: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/58.jpg)
Figure 3 Asthma hospitalization in children from the DNBC presented in a dose-response curve per number of antibiotic prescriptions for nonrespiratory infection the mother received during pregnancy. The risk of asthma increased significantly with increasing number of prescriptions analyzed as a continuous variable, adjusted P value =.01. Number of prescriptions in each category: 27 244 (88.8%) mothers had no prescriptions in pregnancy, 2608 (8.5%) had 1 prescription, 569 (1.9%) had 2 prescriptions, 160 (0.5%) had 3 prescriptions, and 99 (0.3%) mothers had ≥4 prescriptions. Upright bars represent the HR estimates and 95% CI.
Use of Antibiotics during Pregnancy Increases the Risk of Asthma in Early Childhood
Graff L et al. The Journal of Pediatrics 2012; Nov 6. pii: S0022-3476(12)01141-9
![Page 59: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/59.jpg)
Fig 1 Predicted probability of sensitization with 95% CIs by urinary triclosan levels. A, Aeroallergen sensitization for all subjects. B, Food sensitization for male and female subjects .
Savage JH et al. JACI 130;2012;453
Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization
![Page 60: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/60.jpg)
Primary Efficacy Endpoint: Mean Change in Daily Mean Symptom Score
-5.5
-5
-4.5
-4
-3.5
-3
-2.5
-2
-1.5
-1
-0.5
0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 EP
Mea
n C
han
ge
in D
aily
MS
S
DAYS
placebo
FF 110mcg QD
FF 110mcg BID
Keith PK et al. Prim Care Resp J 2012
![Page 61: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/61.jpg)
Role of vitamin D?
67Camargo CA JACI 2007;120:131-6
![Page 62: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/62.jpg)
Role of vitamin D?
Risk of recurrent wheeze
68Camargo CA et al Am J Clin Nutr 2007;85:788 –95
![Page 63: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/63.jpg)
Vitamin D and s-IgE levels vs season
69Hollams EM et al. ERJ Express. May 12, 2011
![Page 64: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/64.jpg)
Risk of atopy – positive relationship only in males 6-14 yo
70Hollams EM et al. ERJ Express. May 12, 2011
![Page 65: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/65.jpg)
Vitamin D supplementation in children 5 to 18 years old may prevent asthma exacerbations
71Majak P et al JACI 2011 May;127(5):1294-6.
![Page 66: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/66.jpg)
![Page 67: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/67.jpg)
ACE inhibitor angioedema
![Page 68: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/68.jpg)
ACE inhibitor use in Canada
Total volume of prescriptions dispensed from Canadian pharmacies for 1 year ending October 2010 (+ compared to year ending October 2009
Total Scripts Change1. Atorvastatin 15,768,000
+2.7%2. Levothyroxine 14,964,000
+5.1%3. Metformin 10,637,000
+8.4%4. Ramipril 9,349,000 -
1.6%47. Perindopril 2,690,000
+17.3%
( IMS Brogan, Canadian Compuscript)
![Page 69: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/69.jpg)
TRUE or FALSE?
1. Intranasal steroids are first line for the treatment of rhinitis when moderate congestion is present TRUE
2. Exposure to hand sanitizer is associate with increased rate of allergen sensitization TRUE
3. Allergy specific IgE levels go up as you Vitamin D levels go down TRUE
![Page 70: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/70.jpg)
![Page 71: Allergies and Asthma Paul Keith MD MSc FRCPC McMaster University President, Canadian Society of Allergy and Clinical Immunology](https://reader035.vdocuments.site/reader035/viewer/2022062307/551c3fa45503460d398b4b72/html5/thumbnails/71.jpg)
Allergies and Asthma
Paul Keith MD MSc FRCPC
McMaster UniversityPresident, Canadian Society of Allergy and Clinical Immunology